newscaster

Standard Chartered’s Strategic Investment Approach for H2 2023: Prioritizing High-Quality Bonds and Cautious Equities

Overweight in high-quality government bonds with a core allocation to equities Lean toward Asia where greater relative value exists across equities and bonds DUBAI, UAE, July 4, 2023 /PRNewswire/ — Standard Chartered announced today its Global Market Outlook report for the second half of 2023, offering insights into major asset classes worldwide. The report advises…

Read More

Experience Enhanced Usability: WeMade Successfully Migrates WeMix Play to Mainnet

Secure transaction support protocol PPP for simpler token swap process Usability enhanced through connection with various mainnets SEOUL, South Korea, July 3, 2023 /PRNewswire/ — WEMIX PLAY, a global blockchain game platform by Wemade, has successfully migrated to the WEMIX3.0 Mainnet on June 29th. Through the mainnet migration, now all games onboard on WEMIX PLAY…

Read More

Attention Investors: Don’t Miss Your Chance to Lead a Class Action Lawsuit Against Icahn Enterprises L.P. with Robbins Geller Rudman & Dowd LLP by Next Week’s Deadline!

Welcome to Our Blog Post Investor Deadline Next Week: What You Need to Know Are you an investor in Icahn Enterprises L.P. (NASDAQ: IEP)? If so, you may be impacted by a recent class action lawsuit filed against the company. The law firm of Robbins Geller Rudman & Dowd LLP has announced that purchasers or…

Read More

Boosted by BOJ Tankan Survey and Overlooking Weak Chinese Manufacturing Data: A Look at the Positive Impact on Asian Markets

Asian Markets Lifted by Positive BoJ Tankan Survey, Overlook Weak Chinese Manufacturing Data Rising Nikkei Index Boosts Market Sentiment Asian markets kicked off the trading week on a positive note, with Japan’s Nikkei index leading the gains. The upbeat mood was largely driven by encouraging results from the Bank of Japan (BoJ) Tankan Survey, which…

Read More

Get Ready to Make Bank: Aeon Biopharma and Priveterra Join Forces for a $125 Million Financing Bonanza!

Welcome to the World of Biopharmaceutical Finance! What’s the deal with financing in the biopharmaceutical industry? Financing represents the minimum cash required to consummate the business combination and bridge AEON through key episodic migraine data readout. It’s like the necessary fuel that keeps the engine of a company running smoothly. Without the proper financing, companies…

Read More